Navigation Links
Exiqon Announces New Grant Program for MicroRNA Research
Date:5/15/2009

Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

(PRWEB) May 15, 2009 -- Exiqon A/S (NASDAQ OMX Copenhagen: "EXQ") today announced the launch of a new research grant program, open to researchers from academic and non-profit institutions across North America.

"We are excited to offer this type of financial support to the research community at-large. Scientists are making ground-breaking discoveries in the field of microRNA research every day, with implications for human medicine in the form of new insights, new therapies and new diagnostics. Now, more than ever, we recommit ourselves to the success of our customers," says Erik Holmlin, Chief Commercial Officer, Exiqon A/S.

The Exiqon Grant Program has been established with an internal seed funding of $25,000, from which awards will be given to researchers to drive projects enhancing the understanding of how microRNA expression and function relates to normal cellular development, and/or disease-related cellular pathways.

Recipients may use Exiqon Grant Program awards for the purchase of any Exiqon microRNA product or service. Exiqon offers a complete product line for microRNA investigation, including products for RNA isolation, Microarray analysis, qRT-PCR analysis, Northern Blotting, In Situ Hybridization, and Knockdown studies. Exiqon also offers microRNA profiling services for both microarray and qRT-PCR analysis, complete with full sample QC and customized data analysis and reporting.

Researchers are invited to submit an abstract, outlining their research area, project goals, and proposed workflow no later than Monday, June 15th, 2009. Award conveyance through the Exiqon Grant Program does not influence, and is not influenced by, any other existing or potential sources of project funding.

Applications are due June 15th, 2009, and may be submitted electronically via a special Grant Program webpage, http://www.exiqon.com/ls/grants. Grant recipients will be announced no later than July 1st, 2009.

Contact
Chris Harbert
Exiqon, Inc.
781-376-4150
888 647 2879

###

Read the full story at http://www.prweb.com/releases/2009/05/prweb2420424.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO
2. BioCryst Pharmaceuticals Announces Presentation of Forodesine Data at the 45th Annual Meeting of the American Society of Clinical Oncology
3. Standard & Poors Announces Changes to U.S. Index
4. WuXi PharmaTech Announces First-Quarter 2009 Results
5. MAP Pharmaceuticals Announces Presentations at the American Thoracic Society International Conference
6. Select Medical Corporation Announces Results for First Quarter Ended March 31, 2009
7. Human Pheromone Sciences Announces First Quarter Results
8. CorVel Announces Fiscal Year Earnings Release Webcast
9. Robert F. Kennedy, Jr. Announces New Food Allergy Initiative Advocacy Steering Committee
10. UTSA announces funding for new faculty research
11. Nektar Announces UCBs Cimzia(R) Approved by U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Exiqon Announces New Grant Program for MicroRNA Research
(Date:4/28/2017)... ... ... Getting enough sleep affects much more than energy – it also has mental and physical ... compromise motor reaction time, which can increase the risk of having a car accident. ... from the NSF to help you sleep better and feel better:, , ...
(Date:4/28/2017)... California (PRWEB) , ... April 28, 2017 , ... ... T8 Direct Replace tubes . These lamps offer an instant energy-saving solution for ... need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... , April 20, 2017 Research ... Pharmacogenomics Market Size, Market Share, Application Analysis, Regional Outlook, Growth ... report to their offering. ... The global pharmacogenomics market was valued at US$ 7,167.6 ... Mn by 2024, expanding at a CAGR of 5.6% from ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
Breaking Medicine Technology: